Former InterMune CEO Indicted for Improper Marketing

Drug Industry Daily
A A
Former InterMune CEO Scott Harkonen has been indicted for wire fraud and Food, Drug and Cosmetic Act (FDCA) violations for his role in creating and disseminating false and misleading information about the efficacy of Actimmune.

To View This Article:

Login

Subscribe To Drug Industry Daily